• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » What to Remember about Lithium

What to Remember about Lithium

July 1, 2003
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue
Daniel Carlat, MD Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
When it comes to Lithium, you can (thankfully) forget all about the P450 enzymes, because they don't touch this salt. Lithium enters the bloodstream, accomplishes its mysterious mood-stabilizing duties, and then is simply whisked out of the body intact by the kidneys via urine. So with Lithium, it's all about kidneys.

There's only one common way for Lithium levels to be decreased, and that's through caffeine intake. Caffeine increases the glomerular filtration rate, causing us to urinate more, leading to indiscriminate losses of solutes, including Lithium.

More to the point though, there are several ways for the kidney to get fooled into retaining too much Lithium. These three drug interactions should be committed to memory:

  1. NSAIDs. This includes every drug in the non-steroidal anti-inflammatory drug category except Aspirin and Clinoril (sulindac). If you have a patient on Lithium who is taking significant ongoing doses of ibuprofen (Motrin, Advil), indomethicin (Indocin), naproxen (Naprosyn, Alleve), or even the new Cox-2 inhibitors such as Vioxx or Celebrex, you'd better be more aggressive about monitoring Lithium levels, which can double. The mechanism is not entirely clear, but may relate to the inhibition of prostaglandins leading to interference with Lithium excretion.

  2. Hydrochlorothiazide. This common diuretic treats hypertension by increasing Na (sodium) excretion in the distal tubule of the kidney, leading to increased urination, decreased total body water, and therefore decreased blood pressure. The kidney doesn't particularly like to see such havoc being played with its finetuned homeostatic mechanism, and actively tries to compensate for the loss of Na by retaining it elsewhere. But Na is very similar to Lithium (Li), and in snatching back up as much Na as it can, the kidney indiscriminately snatches up a lot of Li, causing an increase of up to 40% in Li levels.


When it comes to Lithium, you can forget about P450 enzymes: It’s all about the kidneys


  1. ACE inhibitors (eg, lisinopril, enalapril, and captopril). These blood pressure medications work by inhibiting ACE (Angiotensin Converting Enzyme), which normally converts Angiotensin I to Angiotensin II. Angiotensin II (A-II) is a great molecule if you like vasoconstriction, but if your blood pressure is high, you prefer ACE inhibition, which prevents too much A-II from being created. So how is all this related to Lithium? A-II also promotes the release of aldosterone, which causes the kidney to retain Na. If you lower A-II, you lower aldosterone, and limit the kidney's ability to retain Na. And, just as in hydrochlorothiazide (above), the kidney compensates by conserving Na in other ways, confuses Li for Na, and you get high levels of Li.


As an aside, both dehydration and low sodium diets can increase Lithium levels, by mechanisms similar to those discussed above: in both cases, the kidney’s trying to hold onto sodium. So advise your sun-loving and diet-following patients accordingly.

Bottom line: With your Lithiumtreated patients, remember the big three of Lithium toxicity: NSAIDs, ACE-inhibitors, and Hydrochlorothiazide. The TCR mnemonic is: "With Lithium, No ACE in the Hole." Monitor Li levels carefully when any of these are present.

TCR VERDICT:
Lithium Mnemonic: “No ACE in the Hole”
General Psychiatry
    Carlat 150x150
    Daniel Carlat, MD

    Treating Alcohol Use Disorder—A Fact Book (2023)

    More from this author
    www.thecarlatreport.com
    Issue Date: July 1, 2003
    SUBSCRIBE NOW
    Table Of Contents
    Dr. Vaughan’s Interaction
    Dr. Neil Sandson on Drug Interactions
    What to Remember about Lithium
    Drug-Drug Interactions You Need to Know
    A Basic Course in Drug Metabolism
    St. John’s Hot Flashes
    DOWNLOAD NOW
    Featured Book
    • MFB6eCover.jpg

      Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

      Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto22709844.jpg
      General Psychiatry

      Psychopharm Commandment #10: Don’t Fear these Meds

      Surprising health benefits of our riskiest meds: Lithium, quetiapine, and clozapine.

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.